1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Marketing & Advertising

US FTC Pulling Various Levers To Impose Monetary Relief On False Ad Defendants

 
• By Eileen Francis

The Federal Trade Commission is leveraging other statutory authorities under the FTC Act and working with state regulators to garner monetary relief for consumers in the year since a Supreme Court decision shut down the commission’s longtime pathway for doing so under Sec. 13(b). FTC Bureau of Consumer Protection director Samuel Levine provided an update – and a warning to industry – at the NAD 2022 conference.

The Federal Trade Commission remains committed to pursuing monetary penalties for false advertising claims despite the loss of its sharpest tool for obtaining financial redress under the FTC Act.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

ProBiotix Health Looks To Next Level In Korea’s $450m Probiotics Market

 
• By Tom Gallen

Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.

Principle Relaunches Vitawell To Help Consumers Navigate UK Supplement ‘Minefield’

 
• By Tom Gallen

Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.

Evidence Doesn’t Scratch Substantiation Itch In NAD Review Of MagniLife Gel Pain Relief Claims

 
• By Malcolm Spicer

National Advertising Division finds Magni Group didn’t support claims made on MagniLife Gel packaging, in direct-mail advertisements and online and in social media “Rapid Pain Relief.”

SFI Expands Distribution Of Brain Health Supplement In Europe

 
• By Tom Gallen

Australia's SFI Health looking to take Equazen omega-3 fatty acids supplement to new markets to capitalize on Europe's fast-growing brain health segment.

More from Business

Good News? 90-Day Pause On Most Tariff Changes – Bad News? 125% Rate Imposed Against China

 
• By Malcolm Spicer

US businesses across industry sectors remain apprehensive about higher tariffs going into effect on imports from China after three-month pause allowed on other changes.

KKR Expands Health & Beauty Portfolio With Deal For Sweden’s Karo

 
• By Tom Gallen

Consumer health player Karo is changing hands from EQT to KKR in a deal thought to value the Stockholm-based firm at over €2.5bn.

Clasado Divests Bimuno Prebiotic Consumer Brand To UK’s Eleat

 
• By David Ridley

Eleat's acquisition encompasses Clasado's Bimuno finished supplement product line and customer base, but not its Bimuno GOS proprietary galactooligosaccharide prebiotic ingredient.